ARDIZZONI, ANDREA

ARDIZZONI, ANDREA  

DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE  

Docenti di ruolo di Ia fascia  

Mostra records
Risultati 1 - 20 di 342 (tempo di esecuzione: 0.091 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non–Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial Garon, Edward B.; Lu, Shun; Goto, Yasushi; De Marchi, Pedro; Paz-Ares, Luis; Spigel, David R.; Th...omas, Michael; Yang, James Chih-Hsin; Ardizzoni, Andrea; Barlesi, Fabrice; Orlov, Sergey; Yoshioka, Hiroshige; Mountzios, Giannis; Khanna, Sadhvi; Bossen, Claudia; Carbini, Mariana; Turri, Sabine; Myers, Andrea; Cho, Byoung Chul 2024-01-01 JOURNAL OF CLINICAL ONCOLOGY - 1.01 Articolo in rivista -
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy De Giglio, Andrea; Leonetti, Alessandro; Comito, Francesca; Filippini, Daria Maria; Mollica, Vero...nica; Rihawi, Karim; Peroni, Marianna; Mazzaschi, Giulia; Ricciotti, Ilaria; Carosi, Francesca; Marchetti, Andrea; Rosellini, Matteo; Gagliano, Ambrogio; Favorito, Valentina; Nobili, Elisabetta; Gelsomino, Francesco; Melotti, Barbara; Marchese, Paola Valeria; Sperandi, Francesca; Di Federico, Alessandro; Buti, Sebastiano; Perrone, Fabiana; Massari, Francesco; Pantaleo, Maria Abbondanza; Tiseo, Marcello; Ardizzoni, Andrea 2024-01-01 CANCER IMMUNOLOGY, IMMUNOTHERAPY - 1.01 Articolo in rivista -
Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib Di Federico A.; De Giglio A.; Sperandi F.; Melotti B.; Ardizzoni A.; Gelsomino F. 2024-01-01 ANTI-CANCER DRUGS - 1.01 Articolo in rivista -
Histopathological Evidence for a Non-Inflammatory Mechanism in Osimertinib-Induced Myopathy: A Case Report Rossi S.; Costa R.; di Federico A.; Lo Bianco F.; D'Angelo R.; Asioli G.M.; De Giglio A.; Sperand...i F.; Guarino M.; Rinaldi R.; Ardizzoni A.; Cenacchi G.; Gelsomino F. 2024-01-01 JOURNAL OF THORACIC ONCOLOGY - 1.01 Articolo in rivista -
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary Cavazzoni A.; Salamon I.; Fumarola C.; Gallerani G.; Laprovitera N.; Gelsomino F.; Riefolo M.; Ri...hawi K.; Porcellini E.; Rossi T.; Mazzeschi M.; Naddeo M.; Serravalle S.; Broseghini E.; Agostinis F.; Deas O.; Roncarati R.; Durante G.; Pace I.; Lauriola M.; Garajova I.; Calin G.A.; Bonafe M.; D'Errico A.; Petronini P.G.; Cairo S.; Ardizzoni A.; Sales G.; Ferracin M. 2024-01-01 MOLECULAR THERAPY - 1.01 Articolo in rivista -
Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial Guido, Alessandra; Cuicchi, Dajana; Castellucci, Paolo; Cellini, Francesco; Di Fabio, Francesca; ...Llimpe, Fabiola Lorena Rojas; Strigari, Lidia; Buwenge, Milly; Cilla, Savino; Deodato, Francesco; Macchia, Gabriella; Galietta, Erika; Golfieri, Rita; Ardizzoni, Andrea; Zagari, Rocco Maurizio; Fanti, Stefano; Poggioli, Gilberto; Fuccio, Lorenzo; Morganti, Alessio G 2023-01-01 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING - 1.01 Articolo in rivista Guido A et al, 2023.pdf
Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors Sisi, Monia; Vitale, Giovanni; Fusaroli, Michele; Riefolo, Mattia; Giunchi, Valentina; D’Errico, ...Antonietta; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco 2023-01-01 JTO CLINICAL AND RESEARCH REPORTS - 1.01 Articolo in rivista Sisi et al. JTO CCR 23.pdfSisi et al. JTO CCR supplementary 23.pdf
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC Zhou, Caicun; Solomon, Benjamin; Loong, Herbert H.; Park, Keunchil; Pérol, Maurice; Arriola, Edur...ne; Novello, Silvia; Han, Baohui; Zhou, Jianying; Ardizzoni, Andrea; Mak, M. Perez; Santini, Fernando C.; Elamin, Yasir Y.; Drilon, Alexander; Wolf, Jürgen; Payakachat, Nalin; Uh, Minji K.; Rajakumar, Deborah; Han, Hongmei; Puri, Tarun; Soldatenkova, Victoria; Lin, A. Bence; Lin, Boris K.; Goto, Koichi 2023-01-01 THE NEW ENGLAND JOURNAL OF MEDICINE - 1.01 Articolo in rivista LIBRETTO_nejmoa2309457.pdfnejmoa2309457_research.zip
Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors Rossi, Simone; Cani, Ilaria; Raschi, Emanuel; Comito, Francesca; Rinaldi, Rita; Ardizzoni, Andrea...; Guarino, Maria; Gelsomino, Francesco 2023-01-01 JOURNAL OF CLINICAL ONCOLOGY - 1.04 Replica / breve intervento (e simili) -
Novel therapeutic strategies for recurrent SCLC Moliner, Laura; Zhang, Bingnan; Lamberti, Giuseppe; Ardizzoni, Andrea; Byers, Lauren A.; Califano..., Raffaele 2023-01-01 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - 1.01 Articolo in rivista -
Peripheral nervous system adverse events associated with immune checkpoint inhibitors Rossi S.; Gelsomino F.; Rinaldi R.; Muccioli L.; Comito F.; Di Federico A.; De Giglio A.; Lambert...i G.; Andrini E.; Mollica V.; D'Angelo R.; Baccari F.; Zenesini C.; Madia P.; Raschi E.; Cortelli P.; Ardizzoni A.; Guarino M. 2023-01-01 JOURNAL OF NEUROLOGY - 1.01 Articolo in rivista Rossi_JN_2023.pdf
Predictors of Survival to Immunotherapy and Chemoimmunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis Di Federico, Alessandro; De Giglio, Andrea; Gelsomino, Francesco; Sperandi, Francesca; Melotti, B...arbara; Ardizzoni, Andrea 2023-01-01 JOURNAL OF THE NATIONAL CANCER INSTITUTE - 1.01 Articolo in rivista -
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Fo...llador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea 2022-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; S...calambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna 2022-01-01 TRANSLATIONAL LUNG CANCER RESEARCH - 1.01 Articolo in rivista ADK-VR2 TLCR.pdftlcr-11-11-2216-coif.zip
Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System Raschi E.; Fusaroli M.; Giunchi V.; Repaci A.; Pelusi C.; Mollica V.; Massari F.; Ardizzoni A.; P...oluzzi E.; Pagotto U.; Di Dalmazi G. 2022-01-01 CANCERS - 1.01 Articolo in rivista cancers-14-04610-v2 (2).pdf
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer Noronha, Ashish; Belugali Nataraj, Nishanth; Lee, Joo Sang; Zhitomirsky, Benny; Oren, Yaara; Oste...r, Sara; Lindzen, Moshit; Mukherjee, Saptaparna; Will, Rainer; Ghosh, Soma; Simoni-Nieves, Arturo; Verma, Aakanksha; Chatterjee, Rishita; Borgoni, Simone; Robinson, Welles; Sinha, Sanju; Brandis, Alexander; Kerr, D Lucas; Wu, Wei; Sekar, Arunachalam; Giri, Suvendu; Chung, Youngmin; Drago-Garcia, Diana; Danysh, Brian P; Lauriola, Mattia; Fiorentino, Michelangelo; Ardizzoni, Andrea; Oren, Moshe; Blakely, Collin M; Ezike, Jideofor; Wiemann, Stefan; Parida, Laxmi; Bivona, Trever G; Aqeilan, Rami I; Brugge, Joan S; Regev, Aviv; Getz, Gad; Ruppin, Eytan; Yarden, Yosef 2022-01-01 CANCER DISCOVERY - 1.01 Articolo in rivista 2022 - Cancer Discovery 2666.pdfcd-22-0111_supplementary_excel_file_2_suppse2.zip
Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma Comito, Francesca; Pagani, Rachele; Grilli, Giada; Sperandi, Francesca; Ardizzoni, Andrea; Melott...i, Barbara 2022-01-01 CANCERS - 1.01 Articolo in rivista cancers-14-00271-v2.pdf
Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer Ardizzoni, Andrea; Azevedo, Sergio; Rubio-Viqueira, Belen; Rodriguez-Abreu, Delvys; Alatorre-Alex...ander, Jorge; Smit, Hans J M; Yu, Jinming; Syrigos, Konstantinos; Höglander, Elen; Kaul, Monika; Tolson, Jonathan; Hu, Youyou; Vollan, Hans Kristian; Newsom-Davis, Thomas 2022-01-01 JOURNAL FOR IMMUNOTHERAPY OF CANCER - 1.01 Articolo in rivista e005581.full.pdfjitc-2022-005581supp001_data_supplement.pdf
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes Di Federico, Alessandro; De Giglio, Andrea; Gelsomino, Francesco; De Biase, Dario; Giunchi, Franc...esca; Palladini, Arianna; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea 2022-01-01 CANCERS - 1.01 Articolo in rivista cancers-14-03472-v2.pdfcancers-14-03472-s001.zip
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization Donatella Romaniello, Valerio Gelfo, Federica Pagano, Enea Ferlizza, Michela Sgarzi, Martina Mazz...eschi, Alessandra Morselli, Carmen Miano, Moshit Lindzen, Gabriele D’Uva, Francesco Fazi, Luca Tamagnone, Karim Rihawi, Andrea Ardizzoni, Yosef Yarden, Mattia Lauriola 2022-01-01 - - 4.01 Contributo in Atti di convegno -